Search For "pfizer"
Pfizer's oral drug to stop COVID-19 could be ready next year, says CEO
Updated : 4 years, 11 months ago IST
New York [US], April 28 (ANI): Pfizer CEO Albert Bourla has said that an oral drug for treating coronavirus could be ready next year adding the company is working on two antivirals, an oral and an injectable.
Read More
Study: Only one in four people experience mild systemic side effects from
Updated : 4 years, 11 months ago IST
London [UK], April 28 (ANI): One in four people experience mild, short-lived systemic side effects after receiving either the Pfizer or AstraZeneca vaccine, with headache, fatigue and tenderness the most common symptoms, suggest the findings of a new study.
Read More
US Trade Rep Katherine Tai discusses increasing vaccine production with Pf
Updated : 4 years, 11 months ago IST
Washington [US], April 27 (ANI): United States Trade Representative Katherine Tai on Monday (local time) met virtually with Dr Albert Bourla, Chairman and Chief Executive Officer of Pfizer, to discuss increasing vaccine production and global health issues.
Read More
Pfizer, Moderna COVID-19 vaccines 'do not appear to pose serious risk' dur
Updated : 4 years, 11 months ago IST
Washington [US], April 22 (ANI): The mRNA Covid-19 vaccines by Pfizer/BioNTech and Moderna do not appear to pose any serious risk during pregnancy, according to new data published Wednesday in the New England Journal of Medicine.
Read More
Study of combined use of AstraZeneca, Pfizer vaccines to launch in Spain
Updated : 4 years, 11 months ago IST
Madrid, April 19 (ANI/Sputnik): Clinical trials on the combined use of two vaccines, AstraZeneca and Pfizer, are set to begin in Spain, Raquel Yotti Alvarez, director of the Carlos III Health Institute, announced on Monday.
Read More
Japan to have enough vaccines to inoculate all people over 16 by late Sept
Updated : 4 years, 11 months ago IST
Tokyo [Japan], April 18 (ANI/Sputnik): Japan will have enough coronavirus vaccines to provide them to everyone older than 16 by the end of September, Administrative Affairs Minister Taro Kono said on Sunday, in the wake of successful talks between Prime Minister Yoshihide Suga and Pfizer CEO
Read More
Risk of rare blood clots higher after Covid-19 infection than after vaccin
Updated : 4 years, 11 months ago IST
London [UK], April 16 (ANI): Researchers at Oxford University have found the risk of a rare type of blood clot is low overall, but higher for people who have been infected with Covid-19 than among people who've had the three vaccines authorized in the UK - those made by AstraZeneca, Moderna
Read More
Third dose of COVID-19 vaccine 'likely' needed within 1 year, says Pfizer
Updated : 4 years, 11 months ago IST
New York [US], April 15 (ANI): Pfizer's CEO Albert Bourla on Thursday that COVID-19 vaccine recipients will "likely" need a third dose between six to 12 months after they're fully vaccinated and suggested vaccinations for coronavirus could be needed every year.
Read More
Pfizer asks for expansion of emergency use authorization to vaccinate 12 t
Updated : 4 years, 11 months ago IST
New York [US], April 10 (ANI): Pfizer and BioNTech requested the US Food and Drug Administration (FDA) on Friday for an amendment to its emergency use authorization of its Covid-19 vaccine, to expand its use for children ages 12 to 15 in the United States.
Read More
COVID-19: US begins study assessing allergic reactions to Pfizer, Moderna
Updated : 4 years, 11 months ago IST
Washington [US], April 8 (ANI): US' National Institutes of Health (NIH) announced on Wednesday that it is launching a study to determine the risk of allergic reactions to the Pfizer-BioNTech and Moderna vaccines among certain individuals.
Read More
US launches study of allergic reactions to COVID-19 vaccines
Updated : 4 years, 11 months ago IST
Washington [US], April 8 (ANI): The US National Institutes of Health (NIH) announced Wednesday that it has kicked off a study to determine the risk of allergic reactions to the Pfizer-BioNTech and Moderna Covid-19 vaccines.
Read More
Mexico grants authorisation for emergency use of India's COVID-19 vaccine,
Updated : 4 years, 11 months ago IST
Mexico City [Mexico], April 7 (ANI): The Mexico Federal Commission for the Protection Against Sanitary Risk (Cofepris) on Wednesday has granted authorization for the emergency use of India's first domestically-produced COVID-19 vaccine, Covaxin.
Read More